Novo Nordisk A/S (NVO)

Last Closing Price: 38.26 (2026-10-07)

Non-Performing Assets / Total Loans (Quarterly)

Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made

Novo Nordisk A/S (NVO) Non-Performing Assets / Total Loans data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
$12.21B
$3.27B
$2.66B
$9.55B
$8.00B
$4.21B
$-28.94M
$4.18B
$4.18B
$3.27B
$3.27B
$3.27B
$3.27B
$4.21B
$5.81B
4.44B
4.44B
$0.74
$0.74
Balance Sheet Financials
$32.47B
$36.06B
$60.10B
$92.57B
$37.20B
$18.95B
$20.94B
$58.14B
$34.43B
$15.44B
$34.43B
--
Cash Flow Statement Financials
$12.34B
$-3.81B
$-5.69B
$4.12B
$6.92B
$2.80B
--
$-5.49B
--
Fundamental Metrics & Ratios
0.87
Non-Performing Assets / Total Loans
--
--
0.35
0.63
78.21%
34.48%
34.48%
--
34.24%
26.74%
$8.60B
--
--
--
0.13
0.33
0.72
124.43
9.49%
21.15%
3.53%
6.12%
--
$1.94
$2.78